120 related articles for article (PubMed ID: 17367408)
1. Plasmacytoid dendritic cell leukaemia/lymphoma: towards a well defined entity?
Garnache-Ottou F; Feuillard J; Saas P
Br J Haematol; 2007 Feb; 136(4):539-48. PubMed ID: 17367408
[TBL] [Abstract][Full Text] [Related]
2. Extended diagnostic criteria for plasmacytoid dendritic cell leukaemia.
Garnache-Ottou F; Feuillard J; Ferrand C; Biichle S; Trimoreau F; Seilles E; Salaun V; Garand R; Lepelley P; Maynadié M; Kuhlein E; Deconinck E; Daliphard S; Chaperot L; Beseggio L; Foisseaud V; Macintyre E; Bene MC; Saas P; Jacob MC;
Br J Haematol; 2009 Jun; 145(5):624-36. PubMed ID: 19388928
[TBL] [Abstract][Full Text] [Related]
3. Acute myeloid dendritic cell leukaemia with specific cutaneous involvement: a diagnostic challenge.
Ferran M; Gallardo F; Ferrer AM; Salar A; Pérez-Vila E; Juanpere N; Salgado R; Espinet B; Orfao A; Florensa L; Pujol RM
Br J Dermatol; 2008 May; 158(5):1129-33. PubMed ID: 18294313
[TBL] [Abstract][Full Text] [Related]
4. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
[TBL] [Abstract][Full Text] [Related]
5. CD4+/CD56+ hematodermic neoplasm ("blastic natural killer cell lymphoma"): neoplastic cells express the immature dendritic cell marker BDCA-2 and produce interferon.
Pilichowska ME; Fleming MD; Pinkus JL; Pinkus GS
Am J Clin Pathol; 2007 Sep; 128(3):445-53. PubMed ID: 17709319
[TBL] [Abstract][Full Text] [Related]
6. CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.
Herling M; Jones D
Am J Clin Pathol; 2007 May; 127(5):687-700. PubMed ID: 17439829
[TBL] [Abstract][Full Text] [Related]
7. Plasmacytoid dendritic cell leukemia with potent antigen-presenting ability.
Narita M; Kuroha T; Watanabe N; Hashimoto S; Tsuchiyama J; Tochiki N; Saitoh A; Satoh N; Furukawa T; Toba K; Fuse I; Aizawa Y; Takahashi M
Acta Haematol; 2008; 120(2):91-9. PubMed ID: 18948686
[TBL] [Abstract][Full Text] [Related]
8. A leukemic plasmacytoid dendritic cell line, PMDC05, with the ability to secrete IFN-alpha by stimulation via Toll-like receptors and present antigens to naïve T cells.
Narita M; Watanabe N; Yamahira A; Hashimoto S; Tochiki N; Saitoh A; Kaji M; Nakamura T; Furukawa T; Toba K; Fuse I; Aizawa Y; Takahashi M
Leuk Res; 2009 Sep; 33(9):1224-32. PubMed ID: 19443030
[TBL] [Abstract][Full Text] [Related]
9. CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype.
Urosevic M; Conrad C; Kamarashev J; Asagoe K; Cozzio A; Burg G; Dummer R
Hum Pathol; 2005 Sep; 36(9):1020-4. PubMed ID: 16153467
[TBL] [Abstract][Full Text] [Related]
10. Solitary cutaneous nodule of blastic plasmacytoid dendritic cell neoplasm progressing to overt leukemia cutis after chemotherapy: immunohistology and FISH analysis confirmed the diagnosis.
Kaune KM; Baumgart M; Bertsch HP; Mitteldorf C; Müller-Hermelink HK; Haase D; Ghadimi BM; Schön MP; Neumann C
Am J Dermatopathol; 2009 Oct; 31(7):695-701. PubMed ID: 19684511
[TBL] [Abstract][Full Text] [Related]
11. Blastic plasmacytoid dendritic cell neoplasm: a report of four cases and review of the literature.
Borchiellini D; Ghibaudo N; Mounier N; Del Giudice P; Quinsat D; Ticchioni M; Perrin C; Cardot Leccia N; Lacour JP
J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1176-81. PubMed ID: 22455538
[TBL] [Abstract][Full Text] [Related]
12. Extensive flow cytometric characterization of plasmacytoid dendritic cell leukemia cells.
Gopcsa L; Banyai A; Jakab K; Kormos L; Tamaska J; Matolcsy A; Gogolak P; Rajnavolgyi E; Paloczi K
Eur J Haematol; 2005 Oct; 75(4):346-51. PubMed ID: 16146542
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous accumulation of plasmacytoid dendritic cells associated with acute myeloid leukemia: a rare condition distinct from blastic plasmacytoid dendritic cell neoplasm.
Dargent JL; Delannoy A; Pieron P; Husson B; Debecker C; Petrella T
J Cutan Pathol; 2011 Nov; 38(11):893-8. PubMed ID: 21883371
[TBL] [Abstract][Full Text] [Related]
14. Haematodermic CD4+CD56+ neoplasm: complete remission after methotrexate-asparaginase treatment.
Fontaine J; Thomas L; Balme B; Ronger-Savle S; Traullé C; Petrella T; Dalle S
Clin Exp Dermatol; 2009 Jul; 34(5):e43-5. PubMed ID: 19508475
[TBL] [Abstract][Full Text] [Related]
15. CD4+/CD56+ hematodermic neoplasm: report of a rare variant with a T-cell receptor gene rearrangement.
Stetsenko GY; McFarlane R; Kalus A; Olerud J; Cherian S; Fromm J; George E; Argenyi Z
J Cutan Pathol; 2008 Jun; 35(6):579-84. PubMed ID: 18005171
[TBL] [Abstract][Full Text] [Related]
16. Progress in understanding and managing natural killer-cell malignancies.
Oshimi K
Br J Haematol; 2007 Nov; 139(4):532-44. PubMed ID: 17916099
[TBL] [Abstract][Full Text] [Related]
17. CD4-negative variant of CD4+/CD56+ hematodermic neoplasm: description of three cases.
Ascani S; Massone C; Ferrara G; Rongioletti F; Papini M; Pileri S; Cerroni L
J Cutan Pathol; 2008 Oct; 35(10):911-5. PubMed ID: 18494823
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
Magro CM; Dyrsen ME
J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
[TBL] [Abstract][Full Text] [Related]
19. Identification of CD123+ myeloid dendritic cells as an early-stage immature subset with strong tumoristatic potential.
Shi J; Ikeda K; Maeda Y; Shinagawa K; Ohtsuka A; Yamamura H; Tanimoto M
Cancer Lett; 2008 Oct; 270(1):19-29. PubMed ID: 18555589
[TBL] [Abstract][Full Text] [Related]
20. Malignant hematopoietic cell lines: in vitro models for the study of plasmacytoid dendritic cell leukemia.
Drexler HG; Macleod RA
Leuk Res; 2009 Sep; 33(9):1166-9. PubMed ID: 19423163
[No Abstract] [Full Text] [Related]
[Next] [New Search]